The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

The 2025 "American Idol" champion stops by "GMA" to perform his new single, “Heal,” and reflect on his path to victory. A new Trump administration vaccine policy will limit access to COVID-19 shots.

Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...